| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Ambulatory oxygen and quality of life in interstitial lung disease
|
Page, David B
|
|
2018
|
6 |
10 |
p. 730-731
|
article
|
| 2 |
Black lung is still a threat
|
Morgan, Jules
|
|
2018
|
6 |
10 |
p. 745-746
|
article
|
| 3 |
Changing the treatment landscape for latent tuberculosis with rifampicin
|
Venkatesan, Priya
|
|
2018
|
6 |
10 |
p. 740
|
article
|
| 4 |
Corrections
|
|
|
2018
|
6 |
10 |
p. e53
|
article
|
| 5 |
Corrections
|
|
|
2018
|
6 |
10 |
p. e53
|
article
|
| 6 |
Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trial
|
Visca, Dina
|
|
2018
|
6 |
10 |
p. 759-770
|
article
|
| 7 |
Epigenetic prediction of response to anti-PD-1 treatment in non-small-cell lung cancer: a multicentre, retrospective analysis
|
Duruisseaux, Michäel
|
|
2018
|
6 |
10 |
p. 771-781
|
article
|
| 8 |
Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study
|
Schauwvlieghe, Alexander F A D
|
|
2018
|
6 |
10 |
p. 782-792
|
article
|
| 9 |
IPF diagnosis: flexibility is a virtue
|
Wells, Athol U
|
|
2018
|
6 |
10 |
p. 735-737
|
article
|
| 10 |
Let's add invasive aspergillosis to the list of influenza complications
|
Lamoth, Frederic
|
|
2018
|
6 |
10 |
p. 733-735
|
article
|
| 11 |
Negative trials in critical care medicine and the hurdles
|
Legrand, Matthieu
|
|
2018
|
6 |
10 |
p. e53
|
article
|
| 12 |
Peter Czanyo: lung cancer survivor
|
Reynoso, Cecilia
|
|
2018
|
6 |
10 |
p. 746
|
article
|
| 13 |
Predictive pathology of lung cancer immunotherapy response
|
Petersen, Iver
|
|
2018
|
6 |
10 |
p. 731-733
|
article
|
| 14 |
Six-lobe bronchoalveolar lavage in children with cystic fibrosis
|
Linnane, Barry
|
|
2018
|
6 |
10 |
p. e51
|
article
|
| 15 |
Six-lobe bronchoalveolar lavage in children with cystic fibrosis – Authors' reply
|
Forton, Julian T
|
|
2018
|
6 |
10 |
p. e52
|
article
|
| 16 |
Symptomatic COPD: is it time for triple therapy?
|
Bafadhel, Mona
|
|
2018
|
6 |
10 |
p. 728-729
|
article
|
| 17 |
Taking cystic fibrosis to the stage
|
Ranscombe, Peter
|
|
2018
|
6 |
10 |
p. 743
|
article
|
| 18 |
The long wait for lungs
|
The Lancet Respiratory Medicine,
|
|
2018
|
6 |
10 |
p. 727
|
article
|
| 19 |
The role of glucocorticoids as adjunctive treatment for sepsis in the modern era
|
Marik, Paul E
|
|
2018
|
6 |
10 |
p. 793-800
|
article
|
| 20 |
Tobacco control, lung cancer, and tuberculosis in Singapore
|
Furlow, Bryant
|
|
2018
|
6 |
10 |
p. 741-742
|
article
|
| 21 |
Triple therapy with budesonide/glycopyrrolate/formoterol fumarate with co-suspension delivery technology versus dual therapies in chronic obstructive pulmonary disease (KRONOS): a double-blind, parallel-group, multicentre, phase 3 randomised controlled trial
|
Ferguson, Gary T
|
|
2018
|
6 |
10 |
p. 747-758
|
article
|
| 22 |
Tuberculosis incidence in England hits 30-year low
|
Kirby, Tony
|
|
2018
|
6 |
10 |
p. 744
|
article
|
| 23 |
Understanding irrationality: the key to changing behaviours and improving management of respiratory diseases?
|
Halpin, David M G
|
|
2018
|
6 |
10 |
p. 737-739
|
article
|
Journal description